1.1800
-0.1000
(-7.81%)
As of 10:18:23 AM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Joseph Edward Tucker Ph.D. | CEO & Director | 458.64k | -- | 1969 |
| Mr. Kevin M. Coveney CPA | Chief Financial Officer | 385k | -- | 1965 |
| Dr. Peter J. Facchini Ph.D. | Chief Innovation Officer | 215.27k | -- | 1964 |
Enveric Biosciences, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Corporate Governance
Enveric Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 13, 2025 at 12:30 PM UTC - May 19, 2025 at 12:30 PM UTC
Enveric Biosciences, Inc. Earnings Date
Recent Events
Related Tickers
ONCO Onconetix, Inc.
0.0719
-5.27%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2700
0.00%
AEON AEON Biopharma, Inc.
0.4999
-5.95%
LIXT Lixte Biotechnology Holdings, Inc.
1.1800
+0.85%
REVB Revelation Biosciences, Inc.
2.6250
-6.00%
WINT Windtree Therapeutics, Inc.
1.1500
-6.50%
SLXN Silexion Therapeutics Corp
0.8900
-4.30%
PBM Psyence Biomedical Ltd.
0.5531
-8.58%
HOTH Hoth Therapeutics, Inc.
0.8737
-6.35%
PHIO Phio Pharmaceuticals Corp.
1.0604
-9.45%